SERUM-SOLUBLE INTERLEUKIN-6 RECEPTOR IN MRL/LPR MISE IS ELEVATED WITH AGE AND MEDIATES THE INTERLEUKIN-6 SIGNAL

被引:103
作者
SUZUKI, H
YASUKAWA, K
SAITO, T
NARAZAKI, M
HASEGAWA, A
TAGA, T
KISHIMOTO, T
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 3,1-1-50 FUKUSHIMA,FUKUSHIMA KU,OSAKA 553,JAPAN
[2] TOSOH CORP,BIOTECHNOL RES LAB,KANAGAWA,JAPAN
[3] OSAKA UNIV,INST MOLEC & CELLULAR BIOL,OSAKA,JAPAN
[4] UNIV TOKYO,FAC AGR,DEPT VET INTERNAL MED,TOKYO 113,JAPAN
关键词
INTERLEUKIN-6; SOLUBLE INTERLEUKIN-6 RECEPTOR; MRL-LPR; AUTOIMMUNE DISEASE;
D O I
10.1002/eji.1830230515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The characteristics of soluble interleukin-6 receptor (sIL-6R) in murine sera were examined. To investigate a relationship between serum sIL-6R level and autoimmune diseases, quantitative analysis of serum sIL-6R in MRL/lpr mice was performed by an enzyme-linked immunosorbent assay. The serum sIL-6R level in MRL/lpr mice of both sexes was below the detection limit (< 1.0 ng/ml) at 8 weeks of age, but it increased in accordance with age and reached 42 +/- 9.3 ng/ml in female and 31 +/- 13 ng/ml in male mice at 30 weeks of age. In MRL/+ mice, although an age-associated increase in serum sIL-6R level was observed, it was much less extensive than that in MRL/lpr mice. Elevated serum sIL-6R level at the age of 30 weeks was observed in female and male (NZB x NZW)F1 mice (32 +/- 10 ng/ml and 17 +/- 5.0 ng/ml, respectively), and male BXSB/Mpj Yaa mice (42 +/- 18 ng/ml), suggesting that elevated serum sIL-6R in aged mice is one of the characteristics of autoimmune-prone mice. Quantitative analysis of serum IL-6 in MRL/lpr revealed that the serum sIL-6R level correlated well with the serum IL-6 level. We also showed that sIL-6R in the sera from MRL/lpr mice could mediate the IL-6 functions through the IL-6 signal-transducing receptor component gp130, suggesting that elevated production of sIL-6R may partly contribute to development of autoimmune disease in MRL/lpr mice.
引用
收藏
页码:1078 / 1082
页数:5
相关论文
共 50 条
[41]   Expression of soluble interleukin-6 receptor in malignant ovarian tissue [J].
Rath, Kellie S. ;
Funk, Holly M. ;
Bowling, Marcia C. ;
Richards, William E. ;
Drew, Angela F. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (03) :230.e1-230.e8
[42]   In vitro selection of an RNA aptamer yields an interleukin-6/interleukin-6 receptor interaction inhibitor [J].
Ando, Takehiro ;
Yamamoto, Mizuki ;
Takamori, Yukio ;
Tsukamoto, Keita ;
Fuji, Daisuke ;
Kawakami, Takashi .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2021, 85 (05) :1170-1174
[43]   Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer [J].
Dijkgraaf, Eveline M. ;
Welters, Marij J. P. ;
Nortier, Johan W. R. ;
van der Burg, Sjoerd H. ;
Kroep, Judith R. .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) :3816-3827
[44]   Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma [J].
Wang, YF ;
Chang, SY ;
Tai, SK ;
Li, WY ;
Wang, LS .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (09) :850-858
[45]   The response of circulating levels of the interleukin-6/interleukin-6 receptor complex to exercise in young men [J].
Gray, S. R. ;
Clifford, M. ;
Lancaster, R. ;
Leggate, M. ;
Davies, M. ;
Nimmo, M. A. .
CYTOKINE, 2009, 47 (02) :98-102
[46]   Therapeutic Targeting of the Interleukin-6 Receptor [J].
Tanaka, Toshio ;
Narazaki, Masashi ;
Kishimoto, Tadamitsu .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 :199-219
[47]   Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma [J].
Hans, VHJ ;
Kossmann, T ;
Joller, H ;
Otto, V ;
Morganti-Kossmann, MC .
NEUROREPORT, 1999, 10 (02) :409-412
[48]   No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis [J].
Schmidt, S ;
Papassotiropoulos, A ;
Bagli, M ;
Harzheim, M ;
Heun, R ;
Klockgether, T .
NEUROSCIENCE LETTERS, 2000, 294 (03) :139-142
[49]   INFLUENCE OF ZINC ADMINISTERED BY TOTAL PARENTERAL NUTRITION ON PLASMATIC ZINC LEVELS, ON REACTIVE C PROTEIN, ON SERUM INTERLEUKIN-6 AND ON SERUM INTERLEUKIN-6 SOLUBLE RECEPTOR, IN CRITICAL PATIENTS [J].
Menendez, A. Ma ;
De Portela, Ma L. ;
Weisstaub, A. ;
Montemerlo, H. ;
Guidoni, Ma E. ;
Rusi, F. ;
Zeni, S. .
NUTRICION HOSPITALARIA, 2009, 24 (03) :340-346
[50]   CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis [J].
Padberg, F ;
Feneberg, W ;
Schmidt, S ;
Schwarz, MJ ;
Körschenhausen, D ;
Greenberg, BD ;
Nolde, T ;
Müller, N ;
Trapmann, H ;
König, N ;
Möller, HJ ;
Hampel, H .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 99 (02) :218-223